Opportunistic mycoses among hepatitis patients in Iraq
  • Article Type: Research Article
  • Eurasian Journal of Biosciences, 2020 - Volume 14 Issue 2, pp. 3653-3656
  • Published Online: 30 Sep 2020
  • Open Access Full Text (PDF)


Opportunistic mycoses are the human fungal infections associated with immunocompromised patients. Due to wide world incidences of Hepatitis infections, Opportunistic mycoses became more prevalence among patients with Hepatitis A virus (HAV) , Hepatitis B virus (HBV) and Hepatitis C virus ( HCV) in Iraq. The current study focused on detection of Candida species as an opportunistic mycoses causative agents among HAV, HBV and HCV patients admitted to Misan Hospitals in Iraq. A swab samples from oral cavity were taken from patients with HAV, HBV and HCV during 1st Jan 2018 – 31 December 2018. The present study revealed that Sub- districts residents recorded higher number of viral infections (53) compared with urban residents (37). From total of 90 samples infected with Hepatitis viruses (HAV 40 , HBV 40 , and 10 with HCV) ,11 (27.5%) samples were infected with opportunistic mycoses among HAV patients , 19 (47.5%) from HBV patients and  7( 70%) from HCV patients, whereas Control Group  revealed 14 infections only with Candida species from total of 90 samples (15.5%).  The study recorded   different fungal species from oral cavity included: Candida albicans (32), C.krusei (2), C.dubliniensis(1), C.tropicalis (1) ,and Fusarium verticillioides (1).


  • AASLD-IDSA Hepatitis C Guidance Panel (2020). Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology, Vol.71, No.2.
  • Baumert TF, Juhling F, Ono A, Hoshida Y (2017). Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals. BMC Med. 15: 52.
  • Bhat V, Sharma SM, Shetty V, Shastry CS, Rao R, Shenoy SM, Saha S., Balaji S (2013). Prevalence of Candida associated denture stomatitis (Cads) and speciation of Candida among complete denture wears of south west coast region of Karnataka. NUJHS 3(3).
  • Coffin CS, Fung SK, Ma MM (2012). Management of chronic hepatitis B: Canadian association for the study of the liver consensus guidelines. Can J Gastroenterol. 26(12):917–38.
  • Ergun S, Cekici A, Topcuoglu N, Migliari DA, Külekçi G, Tanyeri H, Isik G (2010). Oral status and Candida colonization in patients with Sjögren's Syndrome. Med Oral Patol Oral Cir Bucal. 15:e310–e315.
  • Gow, NAR, van de Veerdonk FL, Brown AJP, Netea MG (2013). Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol. ; 10(2): 112–122.
  • Höfken T (2013). Candida and Candidiasis. Chapter 5. Microbial Pathogenesis: Infection and Immunity, edited by Uday Kishore and Annapurna Nayak. ©2013 Landes Bioscience and Springer Science+Business Media.
  • Jabra-Rizk MA, Kong EF, Tsui C, Nguyen MH, Clancy CJ, Fidel PL, Noverr M (2016). Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework. J. Infection and Immunity, 84(10):2724-2739.
  • Kumar CP, Menon T, Sundararayan T, Nalini S, Thirunarayan MA, Rajasekaran S, Venkatadesikalu M (2006). Esterase activity of Candida species isolated from immunocompromised hosts. Rev Iberoam Micol. 23:101-103.
  • Kurnatowski P, Kurnatowska AJ (2010). The Immune Response to Fungal Infections. Wiad Parazytol, 56(1):23-7.
  • Lemon SM, Ott JJ, Van Damme P, Shouval D (2018). Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention Journal of Hepatology, 68:167–184.
  • Li Y, Zhao L, Geng N, Zhu W, Liu H, Bai H (2020). Prevalence and characteristics of hepatitis C virus infection in Shenyang City, Northeast China, and prediction of HCV RNA positivity according to serum anti-HCV level: retrospective review of hospital data. Virology Journal, 17:36.
  • McMahon BJ (2010). Natural history of chronic hepatitis B. Clin Liver Dis, 14(3):381–96.
  • Nagao Y, Sata M (2010). Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan. Virol J. 7:375.
  • Nagao Y, Hashimoto K, Sata M (2012). Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases. BMC Gastroenterol, 12:155.
  • Naglik JR, Challacombe SJ, Hube B (2003). Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 67:400–428. http://dx.doi.org/10.1128/MMBR.67.3.400-428.2003
  • Naglik JR, Fidel PL, Odds FC (2008). Animal models of mucosal Candida infection. FEMS Microbiol Lett 283:129–139. http://dx.doi.org/10.1111/j.1574-6968.2008.01160.x
  • Negro F (2014). Epidemiology of hepatitis C in Europe. Dig Liver Dis 46(Suppl 5):S158–64.
  • Paya CV (2001). Prevention of Fungal and Hepatitis Virus Infections in Liver Transplantation. Clinical Infectious Diseases 33(Suppl 1):S47–52.
  • Raju SB, Rajappa S (2011). Isolation and Identification of Candida from the Oral Cavity. International Scholarly Research Network, ISRN Dentistry. 2011:487921, 7 pages. doi:10.5402/2011/487921.
  • Singh DK, Tóth R, Gácser A (2020). Mechanisms of Pathogenic Candida Species to Evade the Host Complement Attack. Frontiers in Cellular and Infection Microbiology. 10:94.
  • Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown Jr RS, Bzowej NH, Wong JB (2018). Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B:AASLD 2018 Hepatitis B Guidance. Hepatology 67(4).
  • Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA (2020). Oral Candidiasis: A Disease of Opportunity. J. Fungi; 6:15.
  • Williams DW, Lewis MAO (2000). Isolation and identification of Candida from the oral cavity. Oral Dis. 6:3-11.


This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.